Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
International Journal of Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Byrd, D. M.
Right arrow Articles by Roegner, M. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Byrd, D. M., III
Right arrow Articles by Roegner, M. L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Endocrine Modulation and the Federal Government

Daniel M. Byrd, III

Center for the Study of Environmental Endocrine Effects, Federal Focus, Inc., Washington, DC, USA

M. Luann Roegner

Novartis Seeds, Cornwalis Drive, Research Triangle Park, North Carolina, USA

Recent events have drawn attention to the hypothesis that some xenobiotics in the environment may elicit toxicities in humans by modulating endocrine pathways. From the perspective of regulatory toxicology, pursuit of this hypothesis w ill prove difficult, because current risk assessment m ethods do not readily apply to substances with very high potencies, reversibility, transgener-ational effects, and subtle biological outcomes. Such xenobiotics typically persist in the body and bioaccumulate in the food chain. Yet the exposures are important only during critical periods of vulnerability, and no sustained bio-markers of these important exposures currently exist. This article describes some recent efforts by federal agencies to pursue the hypothesis, including research planning and screening of potential endocrine modulating xenobiotics and risk assessment of dioxin conflicts with its policy for substances that cause thyroid follicular carcinomas.

Key Words: dioxin • endocrine • estrogen • thyroid • xenobiotic

International Journal of Toxicology, Vol. 17, No. 2, 111-128 (1998)
DOI: 10.1080/109158198226657
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?